Eylea HD 8 MG/0.07 ML vial 0.07ML
Ended Awarded Last action
- Contract number
- SPE2DR26FRRM2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,607
Award facts
- Contract value 100% obligated
- $15,606.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,606.96 to DMS Pharmaceutical Group Inc. for EYLEA HD 8 mg/0.07 mL vials on January 16, 2026, with an ultimate completion date of February 9, 2026. EYLEA is a prescription biologic medication used to treat age-related macular degeneration and other retinal conditions. This delivery order was issued without a set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The contract employs firm fixed-price pricing and is classified as a delivery order type.
This award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $499,999,999 contract awarded in November 2025 that extends through December 2036. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serving as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. The company supplies pharmaceutical products and medical consumables to Department of Defense military healthcare facilities globally, and this delivery order reflects the company's ongoing role as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FRRM2?
SPE2DR26FRRM2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FRRM2 worth?
The government has obligated $15,607 on SPE2DR26FRRM2.
Is contract SPE2DR26FRRM2 an order under another contract?
Yes. SPE2DR26FRRM2 is a delivery order under SPE2DR25D9238, an indefinite delivery contract.
Was contract SPE2DR26FRRM2 competed?
The extent of competition for SPE2DR26FRRM2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award